OH2 Oncolytic Viral Therapy in Solid Tumors

NCT03866525 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Gastrointestinal Cancer

Interventions

BIOLOGICAL: OH2 injection, with or without irinotecan or HX008

Sponsor

Binhui Biopharmaceutical Co., Ltd.